Integrative multi-omics analysis identifies SELL and PRF1 as key immune biomarkers and therapeutic targets in tuberculosis

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher

Authors: Tatyana Tarkina, Awais Ali, Shehzad Ali, Tanya Waseem, Dinara Azanbayeva, Tatiyana Kotlyarova, Zulfiya Jetpisbayeva, Nataliya TSOY

DOI: 10.1007/s00210-026-05606-0

Cited by: 1

References: 78

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Inflammation biomarkers and pathways Malaria Research and Control

References 78